The WHO-5 Well-Being Index: A Validation Study in People with Infertility.
Infertility
Iran
Reliability
Validity
WHO-5
Journal
Iranian journal of public health
ISSN: 2251-6085
Titre abrégé: Iran J Public Health
Pays: Iran
ID NLM: 7505531
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
entrez:
24
1
2020
pubmed:
24
1
2020
medline:
24
1
2020
Statut:
ppublish
Résumé
Infertility is a public health problem and can lead to depressive symptoms. In recent years, the WHO-five Well-being Index (WHO-5) has been used as a screening measure for depression, but study on psychometric properties in people with infertility is scarce. The objective of this study was to examine the reliability and validity of the Persian version of the WHO-5 in people with infertility. Overall, 539 infertile patients from a referral infertility center in Tehran, Iran in the period between May and Aug 2017, completed the WHO-5, along with other psychological measures: the Patient Health Questionnaire-9 (PHQ-9) and the Hospital Anxiety and Depression Scale (HADS). Construct validity and internal consistency of WHO-5 were evaluated using confirmatory factor analysis (CFA) and Cronbach's alpha, respectively. Convergent validity was examined by relationship with PHQ-9 and HADS. The prevalence of poor well-being was 44.3% and that of depression was 18.6%. CFA confirmed the unidimensional factor structure of the WHO-5. Internal consistency of the WHO-5 was good (Cronbach's alpha=0.858). The WHO-5 significantly correlated with the PHQ-9 (r=-0.522), HADS-anxiety (r=-0.524) and HADS-depression (r=-0.630), confirming convergent validity. The WHO-5 is a short and easy to use questionnaire with satisfactory reliability and validity that appears suitable for use as a screening test for depressive symptom in infertile people. In addition, the prevalence of depression and poor well-being was very high in this population.
Sections du résumé
BACKGROUND
BACKGROUND
Infertility is a public health problem and can lead to depressive symptoms. In recent years, the WHO-five Well-being Index (WHO-5) has been used as a screening measure for depression, but study on psychometric properties in people with infertility is scarce. The objective of this study was to examine the reliability and validity of the Persian version of the WHO-5 in people with infertility.
METHODS
METHODS
Overall, 539 infertile patients from a referral infertility center in Tehran, Iran in the period between May and Aug 2017, completed the WHO-5, along with other psychological measures: the Patient Health Questionnaire-9 (PHQ-9) and the Hospital Anxiety and Depression Scale (HADS). Construct validity and internal consistency of WHO-5 were evaluated using confirmatory factor analysis (CFA) and Cronbach's alpha, respectively. Convergent validity was examined by relationship with PHQ-9 and HADS.
RESULTS
RESULTS
The prevalence of poor well-being was 44.3% and that of depression was 18.6%. CFA confirmed the unidimensional factor structure of the WHO-5. Internal consistency of the WHO-5 was good (Cronbach's alpha=0.858). The WHO-5 significantly correlated with the PHQ-9 (r=-0.522), HADS-anxiety (r=-0.524) and HADS-depression (r=-0.630), confirming convergent validity.
CONCLUSION
CONCLUSIONS
The WHO-5 is a short and easy to use questionnaire with satisfactory reliability and validity that appears suitable for use as a screening test for depressive symptom in infertile people. In addition, the prevalence of depression and poor well-being was very high in this population.
Types de publication
Journal Article
Langues
eng
Pagination
2058-2064Informations de copyright
Copyright© Iranian Public Health Association & Tehran University of Medical Sciences.
Déclaration de conflit d'intérêts
Funding This study was founded by Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. Conflict of interest The authors declare that they have no conflict of interest.
Références
Scand J Psychol. 2014 Dec;55(6):567-72
pubmed: 25135454
Diabetes Metab. 2012 Dec;38(6):515-22
pubmed: 22939363
Psychother Psychosom. 1996;65(4):183-90
pubmed: 8843498
Int J Methods Psychiatr Res. 2003;12(2):85-91
pubmed: 12830302
Int J Gynaecol Obstet. 2015 Sep;130(3):253-6
pubmed: 26100348
Diabetes Care. 2007 Aug;30(8):2003-6
pubmed: 17475940
Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33
pubmed: 19378696
Acta Diabetol. 2013 Apr;50(2):117-21
pubmed: 20798962
Cogn Behav Ther. 2011;40(3):216-27
pubmed: 21770844
J Psychosom Obstet Gynaecol. 2009 Mar;30(1):11-20
pubmed: 19308778
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
pubmed: 21896369
Hum Reprod. 2017 Sep 1;32(9):1786-1801
pubmed: 29117321
Health Qual Life Outcomes. 2010 Jan 20;8:8
pubmed: 20089179
Fertil Steril. 1992 Dec;58(6):1158-63
pubmed: 1459266
Psychol Health Med. 2017 Feb;22(2):145-151
pubmed: 26892628
Hum Reprod. 2007 Jun;22(6):1506-12
pubmed: 17376819
Psychiatry Clin Neurosci. 2009 Apr;63(2):141-6
pubmed: 19335382
Diabet Med. 2013 Feb;30(2):e63-9
pubmed: 23072401
Psychol Health Med. 2017 Jan;22(1):44-50
pubmed: 27644175
Int J Reprod Biomed (Yazd). 2016 Jan;14(1):57-62
pubmed: 27141550
Cultur Divers Ethnic Minor Psychol. 2014 Jul;20(3):463-468
pubmed: 25045957
Nurs Health Sci. 2015 Mar;17(1):84-89
pubmed: 25263133
Int J Environ Res Public Health. 2017 May 31;14(6):
pubmed: 28561767
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Hum Reprod. 2011 May;26(5):1112-8
pubmed: 21372046
Psychol Methods. 2002 Mar;7(1):64-82
pubmed: 11928891
Acta Psychiatr Scand. 2013 Apr;127(4):331
pubmed: 23171284
Int J Reprod Biomed (Yazd). 2017 May;15(5):287-296
pubmed: 28744524